Danaher Scoops Up Aldevron In $9.6B Deal


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


  • Danaher Corporation (NYSE:DHRhas agreed to acquire privately-held Aldevron for a cash purchase price of approximately $9.6 billion.
  • Danaher expects to finance the acquisition using cash on hand or proceeds from the issuance of commercial paper.
  • Founded in 1998, Aldevron manufactures plasmid DNA, mRNA, and proteins, serving biotechnology and pharmaceutical customers across research, clinical and commercial applications.
  • It employs around 600 people.
  • Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.
  • Price Action: DHR shares closed at $244.74 on Wednesday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: M&ANewsHealth CareGeneralBriefs